These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells. Gillardin PS; Descamps G; Maiga S; Tessoulin B; Djamai H; Lucani B; Chiron D; Moreau P; Le Gouill S; Amiot M; Pellat-Deceunynck C; Moreau-Aubry A Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295500 [TBL] [Abstract][Full Text] [Related]
6. FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression. Zhang J; Kong X; Zhang Y; Sun W; Wang J; Chen M; Chen X J Pathol; 2020 Jul; 251(3):284-296. PubMed ID: 32304229 [TBL] [Abstract][Full Text] [Related]
7. Overexpressed TP73 induces apoptosis in medulloblastoma. Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635 [TBL] [Abstract][Full Text] [Related]
8. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway. Tuo Z; Zhang J; Xue W Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110 [TBL] [Abstract][Full Text] [Related]
9. Clinical landscape of TP73 structural variants in ATL patients. Hiramatsu H; Yokomori R; Shengyi L; Tanaka N; Mori S; Kiyotani K; Gotoh O; Kusumoto S; Nakano N; Suehiro Y; Ito A; Choi I; Ohtsuka E; Hidaka M; Nosaka K; Yoshimitsu M; Imaizumi Y; Iida S; Utsunomiya A; Noda T; Nishikawa H; Ueda R; Sanda T; Ishida T Leukemia; 2023 Dec; 37(12):2502-2506. PubMed ID: 37864123 [No Abstract] [Full Text] [Related]
10. Meta-analysis of TP73 polymorphism and cervical cancer. Feng H; Sui L; Du M; Wang Q Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128397 [TBL] [Abstract][Full Text] [Related]
11. Relationship between TP73 polymorphism (G4C14-A4T14) and cancer risk: a meta-analysis based on literatures. Yu XJ; Fang F; Xie J Gene; 2011 Sep; 484(1-2):42-6. PubMed ID: 21672615 [TBL] [Abstract][Full Text] [Related]
12. Intronic deletion affecting a negative regulatory region of TP73 is related to breast and colorectal carcinomas. Peña C; Garcia JM; Dominguez G; Silva J; Garcia V; Carcereny E; Vargas J; Provencio M; España P; Bonilla F Genes Chromosomes Cancer; 2004 Mar; 39(3):257-62. PubMed ID: 14732927 [TBL] [Abstract][Full Text] [Related]
13. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation. González R; De la Rosa ÁJ; Rufini A; Rodríguez-Hernández MA; Navarro-Villarán E; Marchal T; Pereira S; De la Mata M; Müller-Schilling M; Pascasio-Acevedo JM; Ferrer-Ríos MT; Gómez-Bravo MA; Padillo FJ; Muntané J PLoS One; 2017; 12(3):e0174326. PubMed ID: 28350813 [TBL] [Abstract][Full Text] [Related]
14. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition. Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399 [TBL] [Abstract][Full Text] [Related]
15. Regulation of the interferon-gamma (IFN-γ) pathway by p63 and Δ133p53 isoform in different breast cancer subtypes. Mehta SY; Morten BC; Antony J; Henderson L; Lasham A; Campbell H; Cunliffe H; Horsfield JA; Reddel RR; Avery-Kiejda KA; Print CG; Braithwaite AW Oncotarget; 2018 Jun; 9(49):29146-29161. PubMed ID: 30018742 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumors. Ohnami S; Ohshima K; Nagashima T; Urakami K; Shimoda Y; Saito J; Naruoka A; Hatakeyama K; Mochizuki T; Serizawa M; Ohnami S; Kusuhara M; Yamaguchi K Mol Cell Biochem; 2017 Jul; 431(1-2):75-85. PubMed ID: 28258440 [TBL] [Abstract][Full Text] [Related]
17. p73 expression in medulloblastoma: TAp73/DeltaNp73 transcript detection and possible association of p73alpha/DeltaNp73 immunoreactivity with survival. Zitterbart K; Zavrelova I; Kadlecova J; Spesna R; Kratochvilova A; Pavelka Z; Sterba J Acta Neuropathol; 2007 Dec; 114(6):641-50. PubMed ID: 17912537 [TBL] [Abstract][Full Text] [Related]
18. Contribution of p53, p63, and p73 to the developmental diseases and cancer. Tomkova K; Tomka M; Zajac V Neoplasma; 2008; 55(3):177-81. PubMed ID: 18348649 [TBL] [Abstract][Full Text] [Related]
19. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53. Xiao S; Wang R; Wu X; Liu W; Ma S DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778 [TBL] [Abstract][Full Text] [Related]
20. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2. Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]